Analysis of medical use of carbon adsorbents in China and additional possibilities in this field achieved in Ukraine

References

• Abe T, Shono M, Kodama T, Kita Y, Fukagawa M, Akizawa T. 2004. Extracorporeal albumin dialysis. Ther Apher Dial. 8:217–222.
   PubMed Web of Science ®Google Scholar
• Awad SS, Rich PB, Kolla S, Younger JG, Reickert CA, Downing VP, Bartlett RH. 1997. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO J. 43:M745–749.
   Web of Science ®Google Scholar
• Bardakhivskaya KI, Nikolaev VG. 2001. DNA-containing plasmoimmunosorbents on the base of activated charcoal powder and carbonic microfibers. Artif Organs. 25:786.
   Google Scholar
• Chang TMS, Coffey JF, Barre P, Gonda A, Dirks JH, Levy M, Lister C. 1973. Microcapsule artificial kidney: treatment of patients with acute drug intoxication. Can Med Assoc J. 108:429–433.
   PubMed Web of Science ®Google Scholar
• Chang TMS, Gonda A, Dirks JH, Coffey JF, Lee-Burns T. 1972. ACAC microcapsule artificial kidney for the long term and short term management of eleven patients with chronic renal failure. Trans Am Soc Artif Intern Organs. 18:465–472.
   PubMedGoogle Scholar
• Chang TMS. 1975. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure. Kidney Int, 7:S387–S392.
   Web of Science ®Google Scholar
• Chang TMS. 2007. Artificial Cells:. Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation,and Cell/Stem CelTherapy. Singapore: World Scientific Publishing Co. Pte. Ltd.
   Google Scholar
• Chen L, Wang Z, Zhai S, Zhang H, Lu J, Chen X. 2013. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis. Int J Artif Organs. 36:489–97. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Chen SJ, Jiang GR, Shan JP, Lu W, Huang HD, Ji G, et al. 2011. Combination of maintenance hemodialysis with hemoperfusion: a safe and effective model of artificial kidney. Int J Artif Organs. 34:339–347.
   PubMed Web of Science ®Google Scholar
• Chen YM, Tang XJ, Xu CX, Li ZM. 1991. Preparation and performance of cross-linked agar encapsulated activated charcoal (CAAC-III). J Microencapsul.8:327–334.
   PubMed Web of Science ®Google Scholar
• Churchwell MD, Pasko DA, Smoyer WE, Mueller BA. 2009. Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis. Nephrol Dial Transplant. 24:231–238.
   PubMed Web of Science ®Google Scholar
• Dehua G, Daxi J, Honglang X, Bin X, Yun L, Leishi L. 2006. Sequential hemoperfusion and continuous venovenous hemofiltration in treatment of severe tetramine poisoning. Blood Purif. 24:524–530.
   PubMed Web of Science ®Google Scholar
• Duan ZJ, Li LL, Ju J, Gao ZH, He GH. 2006. Treatment of hyperbilirubinemia with blood purification in China. World J Gastroenterol. 12:7467–7471.
   PubMed Web of Science ®Google Scholar
• Eretskaya EV, Sakhno LA, Nikolaev VG. 1999. Application sorption: experience in clinical use and prospects of development. Biomater Artif Cells Immob Biotechnol. 19:129–145.
   Google Scholar
• Fernandez Ospina NH, Jimenez Gonzalez S, Carrascosa Romero E. 2009. Activated carbon and silver biocide dressings for diabetic foot. A descriptive analysis. Rev Enferm. 32:8–12.
   PubMedGoogle Scholar
• Fu C, Yu Y, Chen C. 2000. A novel immunoadsorbent for rheumatoid arthritis therapy–preparation and efficacy evaluation. Artif Cells Blood Substit Immobil Biotechnol. 28:409–414.
   PubMed Web of Science ®Google Scholar
• Gao CL, Li BA, Chen CZ, Yu YT, Yuan P, Song JC. 1995. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy. Artif Organs.19:468–469.
   PubMed Web of Science ®Google Scholar
• Gao Y, Chen YL, Deng HY, Zhong F, Li YJ. 2007. [Evaluation of charcoal hemoperfusion in dogs with acute fluoroacetamide poisoning]. Zhonghua Er Ke Za Zhi. 45:661–664.
   PubMedGoogle Scholar
• Griffiths RI, Barron RL, Gleeson ML, Danese MD, O’Hagan A, Chia VM, et al. 2012. Granulocyte-colony stimulating factor use and medical costs after initial adjuvant chemotherapy in older patients with early-stage breast cancer. Pharmacoeconomics. 30:103–118.
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang J, He Q, Zhang L, Zhao J, Zhu Z, et al. 2010. Preparation of millimetre-sized mesoporous carbon spheres as an effective bilirubin adsorbent and their blood compatibility. Chem Commun (Camb). 46:7127–7129.
   PubMed Web of Science ®Google Scholar
• Guo L, Zhang L, Zhang J, Zhou J, He Q, Zeng S, et al. 2009. Hollow mesoporous carbon spheres–an excellent bilirubin adsorbent. Chem Commun (Camb).6071–6073.
   PubMed Web of Science ®Google Scholar
• He F, Xu P, Han L, Zhang J, Wu B, Hong GL, et al. 2012. [To evaluate the therapeutic efficacy of hemoperfusion in treating intermediate symdrome following acute organophosphate poisoning]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 30:863–865.
   PubMedGoogle Scholar
• He NH, Wang YJ, Wang ZW, Liu J, Li JJ, Liu GD, Wang YM. 2004. Effects of hemoperfusion adsorption and/or plasma exchange in treatment of severe viral hepatitis: a comparative study. World J Gastroenterol. 10:1218–1221.
   PubMed Web of Science ®Google Scholar
• Hong B, Ling Z, Songmin H, Tao Z, Ruichao Y. 2012. Continuous venovenous hemofiltration and hemoperfusion in successful treatment of a patient with crush syndrome and acute pancreatitis. Ren Fail. 34:383–386.
   PubMed Web of Science ®Google Scholar
• Hsu CW, Lin JL, Lin-Tan DT, Chen KH, Yen TH, Wu MS, Lin SC. 2012. Early hemoperfusion may improve survival of severely Paraquat-poisoned patients. PLoS One. 7(10):e48397.
   Web of Science ®Google Scholar
• Huang Z, Wang SR, Su W, Liu JY. 2010. Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column. Ther Apher Dial. 14:596–602.
   PubMed Web of Science ®Google Scholar
• Hui DS, Lee N, Chan PK. 2013. Adjunctive therapies and immunomodulatory agents in the management of severe influenza. Antiviral Res. 98:410–416.
   PubMed Web of Science ®Google Scholar
• Karalliedde L, Baker D, Marrs TC. 2006. Organophosphate-induced intermediate syndrome: aetiology and relationships with myopathy. Toxicol Rev. 25:1–14.
   PubMedGoogle Scholar
• Kong DL, Chen CZ, Lin EF, Yu YT. 1998. Clinical trials of type I and in vitro studies of type II immunoadsorbents for systemic lupus erythematosus therapy. Artif Organs. 22:644–650.
   PubMed Web of Science ®Google Scholar
• Lai DP, Ren XH, Yao JP, Liu ML, Xu G, Chen ZJ, Ling GL. 2012. [Study on the effect using hemoperfusion to treat tylenol poisoned patients]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 30:310–312.
   PubMedGoogle Scholar
• Lai DP, Wang JF, Yao JP, Wang YF, Cheng GQ. 2011. [The assessment of hemoperfusion for the treatment of acute methamidophos poisoning]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 29:440–442.
   PubMedGoogle Scholar
• Li G, Wan J, Huang X, Zeng Q, Tang J. 2011. [Comparison study on adsorption of middle molecular substances with multiwalled carbon nanotubes and activated carbon]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 28:758–762.
   PubMedGoogle Scholar
• Li LJ, Yang Q, Huang JR, Xu XW, Chen YM, Fu SZ. 2004. Effect of artificial liver support system on patients with severe viral hepatitis: a study of four hundred cases. World J Gastroenterol. 10:2984–2988.
   PubMed Web of Science ®Google Scholar
• Li LJ, Zhang YM, Liu XL, Du WB, Huang JR, Yang Q, et al. 2006. Artificial liver support system in China: a review over the last 30 years. Ther Apher Dial. 10:160–167.
   PubMed Web of Science ®Google Scholar
• Lin YH, Lin JH, Wang SH, Ko TH, Tseng GC. 2012. Evaluation of silver-containing activated carbon fiber for wound healing study: In vitro and in vivo. J Biomed Mater Res B Appl Biomater. 100:2288–2296.
   PubMedGoogle Scholar
• Liu P, Liang YG, Meng QY, Zhang CG, Wang HC, Zhang XG, et al. 2012. Successful therapy with hemoperfusion and plasma exchange in acute 1,2,3-trichloropropane poisoning. Hum Exp Toxicol. 31:523–527.
   PubMed Web of Science ®Google Scholar
• Lu Y, Gong Q, Lu F, Liang J, Ji L, Nie Q, Zhang X. 2011. Preparation of sulfonated porous carbon nanotubes/activated carbon composite beads and their adsorption of low density lipoprotein. J Mater Sci Mater Med. 22:1855–1862.
   PubMed Web of Science ®Google Scholar
• Lu YQ, Jiang JK, Huang WD. 2011. Clinical features and treatment in patients with acute 2,4-dinitrophenol poisoning. J Zhejiang Univ Sci B. 12:189–192.
   PubMed Web of Science ®Google Scholar
• Nakaji S, Hayashi N. 2003. Bilirubin adsorption column Medisorba BL-300. Ther Apher Dial. 7:98–103.
   PubMed Web of Science ®Google Scholar
• Nikolaev VG, Ryabov SI, Pyrig LA, Strelko VV, Shostka GD, Kartel NT. 1985. Unconventional methods of activated carbon application in chronic renal diseases therapy. Nefrologia Mexicana. 6:148.
   Google Scholar
• Nikolaev VG, Strelko VV, Korovin UF. 1982. Theoretical base and field of practical use of enterosorption method. In: Sorption methods of detoxification and immune correction in medicine. Kharkov, 112–114. (In Russian).
   Google Scholar
• Nikolaev VG, Vychalkovsky AF, Matyash VI, Titkovsky SP. 1998. The first use of carbon enterosorbent “Belosorb” for treatment of gastroenteral and diarrhea syndromes in patients with severe cholera. In: Modern aspects of military medicine. Kiev, 147–149. (In Russian).
   Google Scholar
• Nikolaev VG. 1984a. Enterosorption. In: Chang TMS, Lin HB, Eds. Proceedings of the Fifth Int. Symp. on Hemoperfusion and Artificial Organs. China: Academic Publishers, pp. 87–99.
   Google Scholar
• Nikolaev VG. 1984b. Hemocarboperfusion in Experiment and Clinic. Kiev, Ukraine: Naukova Dumka. (In Russian).
   Google Scholar
• Pat. № 1726782 CN, IPC: A01N59/16, A01N25/08, A41D13/12, A61L15/18, A01N59/16, A01N25/08, A41D13/12, A61L15/16./[CN].Song Jianxing Wu, NO 2 ARMY MED. COLLEGE P L [CN] —3. №. 20051024952; Stat. 07.04.2005; Pub. 01.02.2006. Composite antibiotic material in medical use of active carbon fiber_ Nano silver, and preparation method.
   Google Scholar
• Pat. № 2652362 CN, IPC: A61F13/00; A61F13/00; (IPC1-7): A61F13/00./Wang Tonghua, Yan Kaixing, UNIV DALIAN SCI, & ENG [CN]. —3. №. 20032084723; Stat. 12.09.2003; Pub. 03.11.2004. Composite medical active carbon fiber dressing.
   Google Scholar
• Peng A, Meng FQ, Sun LF, Ji ZS, Li YH. 2004. Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning. Acta Pharmacol Sin. 25:15–21.
   PubMed Web of Science ®Google Scholar
• Ponomareva OV, Pivnyuk VM, Nosko MM, Sakhno LA, Dektyar TV, Nikolaev VG, Chekhun VF. 2008. Prophylaxis by coal enterosorbent of acute and extended emethogenic toxicity of cancer patient chemotherapy. Oncology. 10:370–373 (In Ukrainian).
   Google Scholar
• Qiao Y, Zhao J, Li P, Wang J, Feng J, Wang W, et al. 2010. Adsorbents with high selectivity for uremic middle molecular peptides containing the Asp-Phe-Leu-Ala-Glu sequence. Langmuir. 26:7181–7187.
   PubMed Web of Science ®Google Scholar
• Qiu QM, Liu Y, Song Q, Ge Y, Hong GL, Lu ZQ, et al. 2012. [Effects of hemoperfusion on oxidative stress, matrix metalloproteinases and their inhibitors in acute paraquat poisoning rabbits]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 30:89–96.
   PubMedGoogle Scholar
• Sakhno LA, Yurchenko OV, Maslenniy VN, Bardakhivskaya KI, Nikolaeva VV, Ivanyuk AA, et al. 2013. Enterosorption as a method to decrease the systemic toxicity of cisplatin. Exp Oncol. 35:45–52.
   PubMedGoogle Scholar
• Sakhno LA., Nikolaev VG, Lozinskaya IA, Yudin VM. 1991. Basic studies of local adsorption in burn treatment. Biomat Artif Cells Immob Biotech. 19:111–128.
   PubMed Web of Science ®Google Scholar
• Sarnatskaya VV, Lindup WE, Walther P, Maslenny VN, Yushko LA, Sidorenko AS, et al. 2002. Albumine, bilirubine and activated carbon: new edges of an old triangle. Artif Cells Blood Substit Immobil Biotechnol. 2:113–127.
   Google Scholar
• Sarnatskaya VV, Yushko LA, Korneeva LN, Sakhno LA, Maslenny VN, Snezhkova EA, Mikhalovsky SV. 2005. Biolization of the surface of high active carbon adsorbents by conformers of human serum albumin. Efferent Therapy. 11:10–20.
   Google Scholar
• Sarnatskaya VV, Yushko LA, Nikolaev AV, Grinenko DV, Nikolaev VG. 2007. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients. Biomater Artif Cells Artif Organs. 35:287–309.
   Google Scholar
• Shi Y, Bai Y, Zou Y, Cai B, Liu F, Fu P, Wang L. 2012. The value of plasma paraquat concentration in predicting therapeutic effects of haemoperfusion in patients with acute paraquat poisoning. PLoS One. 7:e40911.
   Web of Science ®Google Scholar
• Snezhkova EA, Muller D, Bardakhivskaya KI, Mikhalovsky SM, Nikolaev VG. 2004. High-porosity activated carbon as a possible matrix for native DNA and dextran-sulfate immobilization. Artif Cells Blood Substit Biotechnol. 32:529–537.
   PubMedGoogle Scholar
• Song J, Li H, Zhang XD. 2010. [Influence of different blood purification treatment on the serum leptin and neuropeptide Y levels in patients with chronic renal failure]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 26:1116–1118.
   PubMedGoogle Scholar
• Song JR, Huang MX, Mao HX, Zhou HM. 2010. [Application of hemoperfusion in children with acute tetramine poisoning]. Zhongguo Dang Dai Er Ke Za Zhi. 12:536–538.
   PubMedGoogle Scholar
• Talbot AR. 1989. A comparison of hemoperfusion columns for paraquat. Vet Hum Toxicol. 31:131–135.
   PubMedGoogle Scholar
• Tang T, Li X, Xu Y, Wu D, Sun Y, Xu J, Deng F. 2011. Bilirubin adsorption on amine/methyl bifunctionalized SBA-15 with platelet morphology. Colloids Surf B Biointerfaces. 84:571–578.
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhang L, Fu P, Kang Y, Liu F. 2012. Hemoperfusion plus continuous veno-venous hemofiltration in a pregnant woman with severe acute pancreatitis: a case report. Int Urol Nephrol. 44:987–990.
   PubMed Web of Science ®Google Scholar
• Ternovoy KS, Pinchuk LB, Nikolaev VG, Kravchenko NP, Pinchuk VG, Ritter NK, et al. 1983. Hemocarboperfusion in the Treatment of the Acute Radiation Disease. Kiev, Ukraine: Naukova Dumka. (In Russian).
   Google Scholar
• Todurov BM, Kovtun GI. 2011. Hemoimmunoprecipitation — a new approach for therapy of dilated cardiomyopathy. Heart Insufficiency. 1:72–78 (In Russian).
   Google Scholar
• Wang YJ, Yu YT. 2011. Development of resin adsorbents for blood purification at Nankai University in China. Artif Cells Blood Substit Immobil Biotechnol. 39:92–97.
   PubMed Web of Science ®Google Scholar
• Wu BF, Wang MM. 2004. Molecular adsorbent recirculating system in dealing with maternal Amanita poisoning during the second pregnancy trimester: a case report. Hepatobiliary Pancreat Dis Int. 3:152–154.
   PubMedGoogle Scholar
• Yang Y, Yu YT, Song JC, Qian SC, Quan WL, Shao XH, et al. 1988. A new DNA immune adsorbent for hemoperfusion in SLE therapy: a clinical trial. Artif Organs. 12:444–446.
   PubMed Web of Science ®Google Scholar
• Yu YT, Chen CZ.Advances of adsorbents for hemoperfusion in China. 1990. Biomater Artif Cells Artif Organs. 18:499–505.
   PubMedGoogle Scholar
• Yu Z, Wu R, Zou H. 2010. [Preparation of bovine serum albumin immobilized adsorbent for specific adsorption of bilirubin]. Se Pu. 28:291–295.
   PubMedGoogle Scholar
• Zhang L, Jin G. 2005. Bilirubin removal from human plasma by Cibacron Blue F3GA using immobilized microporous affinity membranous capillary method. J Chromatogr B Analyt Technol Biomed Life Sci. 821:112–121.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wu WZ, Lu YQ, Wang JZ, Shang AD, Yao F, Chen Y. 2012. Successful treatment of patients with paraquat intoxication: three case reports and review of the literature. J Zhejiang Univ Sci B. 13:413–418.
   PubMed Web of Science ®Google Scholar
• Zhao G, Ding M, Zhang B, Lv W, Yin H, Zhang L, et al. 2008. Clinical manifestations and management of acute thallium poisoning. Eur Neurol.60:292–297.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhan C, Li Y, Zhong Q, Pan H, Yang G. 2010. Intravenous lipid emulsions combine extracorporeal blood purification: a novel therapeutic strategy for severe organophosphate poisoning. Med Hypotheses. 74:309–311.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Dong Y, Xu DL, Jiang JY. 2013. [Application of continuous blood purification combined with hemoperfusion in the treatment of hemolytic-uremic syndrome in children]. Zhongguo Dang Dai Er Ke Za Zhi. 15:53–55.
   PubMedGoogle Scholar